Display options
Share it on

PLoS One. 2015 Apr 14;10(4):e0124301. doi: 10.1371/journal.pone.0124301. eCollection 2015.

Attenuation of progressive hearing loss in DBA/2J mice by reagents that affect epigenetic modifications is associated with up-regulation of the zinc importer Zip4.

PloS one

Hideki Mutai, Fuyuki Miya, Masato Fujii, Tatsuhiko Tsunoda, Tatsuo Matsunaga

Affiliations

  1. Laboratory of Auditory Disorders, Division of Balance and Hearing Research, National Institute of Sensory Organs, National Tokyo Medical Center, Meguro, Tokyo, Japan.
  2. Laboratory for Medical Science Mathematics, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
  3. Division of Balance and Hearing Research, National Institute of Sensory Organs, National Tokyo Medical Center, Meguro, Tokyo, Japan.

PMID: 25875282 PMCID: PMC4397065 DOI: 10.1371/journal.pone.0124301

Abstract

Various factors that are important for proper hearing have been identified, including serum levels of zinc. Here we investigated whether epigenetic regulatory pathways, which can be modified by environmental factors, could modulate hearing. RT-PCR detected expression of genes encoding DNA methyltransferase and histone deacetylase (Hdac) in the postnatal as well as adult mouse auditory epithelium. DBA/2J mice, which are a model for progressive hearing loss, were injected subcutaneously with one or a combination of the following reagents: L-methionine as a methyl donor, valproic acid as a pan-Hdac inhibitor, and folic acid and vitamin B12 as putative factors involved in age-related hearing loss. The mice were treated from ages 4 to 12 weeks (N ≥ 5), and auditory brainstem response (ABR) thresholds were measured at 8, 16, and 32 kHz. Treatment of the mice with a combination of L-methionine and valproic acid (M+V) significantly reduced the increase in the ABR threshold at 32 kHz. Treatment with any of these reagents individually produced no such effect. Microarray analyses detected 299 gene probes that were significantly up- or down-regulated in the cochleae of mice treated with M+V compared with the control vehicle-treated mice. Quantitative RT-PCR confirmed significant up-regulation of a zinc importer gene, Zip4, in the cochleae of mice treated with M+V. Immunohistochemistry demonstrated an intense Zip4 signal in cochlear tissues such as the lateral wall, organ of Corti, and spiral ganglion. Finally, mice treated with the Zip4 inducer (-)-epigallocatechin-3-O-gallate showed a significant reduction in the increase of the ABR threshold at 32 kHz and up-regulation of Zip4 expression in the cochlea. This study suggests that epigenetic regulatory pathways can modify auditory function and that zinc intake in the cochlea via Zip4 mediates maintenance of mammalian hearing.

References

  1. Am J Clin Nutr. 1999 Mar;69(3):564-71 - PubMed
  2. Development. 1999 Jun;126(11):2335-43 - PubMed
  3. Neurotoxicology. 1999 Oct;20(5):731-48 - PubMed
  4. J Am Acad Audiol. 1999 Sep;10(8):436-44 - PubMed
  5. Audiology. 2000 Mar-Apr;39(2):80-7 - PubMed
  6. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17095-100 - PubMed
  7. Bioinformatics. 2003 Jan 22;19(2):185-93 - PubMed
  8. J Biol Chem. 2003 Aug 29;278(35):33474-81 - PubMed
  9. Nat Genet. 2003 Sep;35(1):21-3 - PubMed
  10. Nat Genet. 2003 Dec;35(4):315-7 - PubMed
  11. Biol Psychiatry. 2005 Mar 1;57(5):500-9 - PubMed
  12. Laryngoscope. 2006 Feb;116(2):292-6 - PubMed
  13. Acta Otolaryngol. 2006 Dec;126(11):1148-57 - PubMed
  14. Ann Intern Med. 2007 Jan 2;146(1):1-9 - PubMed
  15. Hum Mol Genet. 2007 Jun 15;16(12):1391-9 - PubMed
  16. Audiol Neurootol. 2007;12(6):345-58 - PubMed
  17. Hear Res. 2007 Nov;233(1-2):1-13 - PubMed
  18. Brain Res. 2007 Nov 28;1182:26-33 - PubMed
  19. Int J Dev Neurosci. 2008 Apr;26(2):217-23 - PubMed
  20. Brain Res. 2008 May 30;1212:9-17 - PubMed
  21. J Neurosci Methods. 2008 Jun 30;171(2):279-87 - PubMed
  22. Ann Otol Rhinol Laryngol. 1991 Aug;100(8):647-9 - PubMed
  23. J Neurochem. 2009 Mar;108(5):1226-36 - PubMed
  24. Neuroscience. 2009 Nov 10;163(4):1255-63 - PubMed
  25. Dev Neurobiol. 2009 Dec;69(14):913-30 - PubMed
  26. Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19432-7 - PubMed
  27. J Nutr Biochem. 2011 Feb;22(2):153-63 - PubMed
  28. J Neurosci. 2010 Jul 21;30(29):9683-94 - PubMed
  29. Laryngoscope. 2011 Mar;121(3):617-21 - PubMed
  30. Otolaryngol Head Neck Surg. 2010 Dec;143(6):826-30 - PubMed
  31. Epigenomics. 2010 Oct;2(5):657-69 - PubMed
  32. Nat Genet. 2011 Jun;43(6):595-600 - PubMed
  33. Am J Clin Nutr. 2011 Aug;94(2):679S-84S - PubMed
  34. Biochem Pharmacol. 2011 Dec 15;82(12):1807-21 - PubMed
  35. Neuroreport. 2012 Mar 7;23(4):201-5 - PubMed
  36. J Pharmacol Sci. 2012;118(3):363-72 - PubMed
  37. PLoS One. 2012;7(5):e36066 - PubMed
  38. Aging Clin Exp Res. 2012 Dec;24(6):603-11 - PubMed
  39. Learn Mem. 2013 Jan 15;20(2):61-74 - PubMed
  40. Mol Aspects Med. 2013 Apr-Jun;34(2-3):548-60 - PubMed
  41. Mol Aspects Med. 2013 Apr-Jun;34(2-3):612-9 - PubMed
  42. Eur Arch Otorhinolaryngol. 1990;247(5):267-70 - PubMed
  43. Hum Mol Genet. 2014 Jun 1;23(11):2888-900 - PubMed
  44. Oxid Med Cell Longev. 2014;2014:582849 - PubMed
  45. Am J Otolaryngol. 2015 Mar-Apr;36(2):230-4 - PubMed
  46. Am J Otol. 1989 Mar;10(2):156-60 - PubMed
  47. Arch Otorhinolaryngol. 1987;244(3):190-3 - PubMed
  48. Am J Otol. 1985 Jan;6(1):116-7 - PubMed
  49. J Biol Chem. 1994 May 13;269(19):13748-51 - PubMed
  50. Acta Otolaryngol. 1994 Mar;114(2):167-76 - PubMed
  51. Acta Otolaryngol. 1996 Nov;116(6):833-5 - PubMed
  52. Nihon Jibiinkoka Gakkai Kaiho. 1997 Sep;100(9):915-9 - PubMed
  53. Hear Res. 1998 May;119(1-2):27-36 - PubMed

Substances

MeSH terms

Publication Types